aTYR PHARMA (ATYR) EPS (Basic) (2014 - 2026)
aTYR PHARMA's (ATYR) quarterly EPS (Basic) came in at -$0.14 in Q1 2026, up 33.14% YoY from -$0.1 in Q1 2025, and up 13.76% on a QoQ basis from -$0.16 in Q4 2025.
aTYR PHARMA (ATYR) EPS (Basic) (2014 - 2026) Analysis & Trends
aTYR PHARMA (ATYR) has 13 years of EPS (Basic) data on file, last reported at -$0.14 in Q1 2026.
- Quarterly EPS (Basic) rose 33.14% year-over-year to -$0.14 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.81 (up 9.04% YoY) and the FY2025 annual result came in at -$2.36, up 8.62% from the prior year.
- EPS (Basic) advanced to -$0.14 in Q1 2026, from -$0.16 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.14 in Q1 2026 to a low of -$0.71 in Q3 2022.
- A 5-year average of -$0.33 and a median of -$0.3 in 2023 frame the typical range for EPS (Basic).
- The widest YoY moves for EPS (Basic): up 94.22% in 2022, down 64.23% in 2022.
- Tracing ATYR's EPS (Basic) over 5 years: stood at -$0.28 in 2022, then slipped by 5.96% to -$0.3 in 2023, then advanced by 28.48% to -$0.21 in 2024, then grew by 25.35% to -$0.16 in 2025, then increased by 13.76% to -$0.14 in 2026.
- The last three EPS (Basic) figures came in at -$0.14 (Q1 2026), -$0.16 (Q4 2025), and -$0.3 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.29 Bn | 132.43 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.58 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 61.87 Bn | 56.73 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.90 Bn | 10.51 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | 0.18 |
| 10 | aTYR PHARMA | 51.00 Mn | -6.42 Mn | - | -0.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.13 |
| Mar 31, 2026 | -0.14 |
| Dec 31, 2025 | -0.16 |
| Sep 30, 2025 | -0.30 |
| Jun 30, 2025 | -0.25 |
| Mar 31, 2025 | -0.21 |
| Dec 31, 2024 | -0.21 |
| Sep 30, 2024 | -0.26 |
| Jun 30, 2024 | -0.32 |
| Mar 31, 2024 | -0.35 |
| Dec 31, 2023 | -0.30 |
| Sep 30, 2023 | -0.33 |
| Jun 30, 2023 | -0.36 |
| Mar 31, 2023 | -0.46 |
| Dec 31, 2022 | -0.28 |
| Sep 30, 2022 | -0.71 |
| Jun 30, 2022 | -0.48 |
| Mar 31, 2022 | -0.49 |
| Dec 31, 2021 | -4.87 |
| Sep 30, 2021 | -0.43 |